0-2 days old   3-7 days old   8-14 days old
Modified in Last 14 Days

Other Bob's Good Stuff Lists Pages Bookstore Diabetes Mailing List Archives Message Forums

[ About the Diabetes Lists | People With Disabilities ]

Links:

Precautions Changed for Diabetic Peripheral Neuropathic Pain Medication [ Hits: 23 | Rating: 0.00 | Votes: 0 ] [ Added: 17-Oct-2005 | Modified: 17-Oct-2005 ] [ Rate This Link ] MONDAY, October 17 (MedWatch) -- Eli Lilly and FDA notified healthcare professionals of revision to the PRECAUTIONS/Hepatotoxicity section of the prescribing information for Cymbalta (duloxetine hydrochloride), indicated for treatment of major depressive disorder and diabetic peripheral neuropathic pain. Postmarketing reports of hepatic injury (including hepatitis and cholestatic jaundice) suggest that patients with preexisting liver disease who take duloxetine may have an increased risk for further liver damage.

Related Categories:

Diabetes : News : 2005 : 01 Diabetes news during January 2005 Diabetes : News : 2005 : 02 Diabetes news during February 2005 Diabetes : News : 2005 : 03 Diabetes news during March 2005 Diabetes : News : 2005 : 04 Diabetes news during April 2005 Diabetes : News : 2005 : 05 Diabetes news during May 2005 Diabetes : News : 2005 : 06 Diabetes news during June 2005 Diabetes : News : 2005 : 07 Diabetes news during July 2005 Diabetes : News : 2005 : 08 Diabetes news during August 2005 Diabetes : News : 2005 : 09 Diabetes news during September 2005 Diabetes : News : 2005 : 11 Diabetes news during November 2005   Diabetes : News : 2005 : 12 Diabetes news during December 2005

Rated Safe For All Ages